Novo Nordisk
NVO
505 hedge funds and large institutions have $10.7B invested in Novo Nordisk in 2015 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 181 increasing their positions, 179 reducing their positions, and 42 closing their positions.
342% more call options, than puts
Call options by funds: $36.4M | Put options by funds: $8.25M
78% more funds holding in top 10
Funds holding in top 10: 18 → 32 (+14)
33% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 42
25% more capital invested
Capital invested by funds: $8.56B → $10.7B (+$2.17B)
1% more funds holding
Funds holding: 500 → 505 (+5)
1% more repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 179
0.11% less ownership
Funds ownership: 19.06% → 18.96% (-0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$181M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$60M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$34.9M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$30.3M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$114M |
| 2 |
O
OppenheimerFunds
New York
|
-$80.1M |
| 3 |
Renaissance Technologies
New York
|
-$50.7M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$43.3M |
| 5 |
Jennison Associates
New York
|
-$31M |
NVO Hedge Fund Activity: Q1 2015 in Review
505 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2015, worth a combined $10.7B — up 25% from $8.56B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new NVO positions and 42 closed out — a net gain of 14 holders — while 181 added to existing stakes and 179 trimmed.
The largest buyer was Ameriprise, adding an estimated $181M. The largest seller was Arrowstreet Capital, cutting an estimated $114M.
- 505 institutional investors held Novo Nordisk (NVO) as of Q1 2015, up from 500 in Q4 2014.
- Funds reported $10.7B of Novo Nordisk stock for Q1 2015, up 25% quarter-over-quarter.
- 56 funds opened new Novo Nordisk positions in Q1 2015 and 42 closed out, a net change of +14 holders.
- The largest Novo Nordisk buyer in Q1 2015 was Ameriprise, an estimated $181M added.
- The largest Novo Nordisk seller in Q1 2015 was Arrowstreet Capital, an estimated $114M sold.
Based on aggregated 13F filings for Q1 2015.